Evolocumab

Red

Brand Name(s):Repatha

Indication:Hypercholesterolaemia and mixed dyslipidaemia. Homozygous familial hypercholesterolaemia

Rationale:

Considered:Aug-15

Review Date:Jul-23

Comments:
NICE TA 394 Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia
June 2016…………………………2020 Updated SPC which states no longer a requirement for caution when used in patients with renal impairment.